tiprankstipranks
Advertisement
Advertisement

TENX Stock Latest News

Tenax Therapeutics downgraded to Neutral from Buy at Chardan
The FlyTenax Therapeutics downgraded to Neutral from Buy at Chardan
12d ago
TENX
Tenax Therapeutics price target lowered to $4 from $35 at Canaccord
PremiumThe Fly
Tenax Therapeutics price target lowered to $4 from $35 at Canaccord
12d ago
TENX
Tenax Therapeutics price target lowered to $4 from $40 at Guggenheim
PremiumThe Fly
Tenax Therapeutics price target lowered to $4 from $40 at Guggenheim
12d ago
TENX
Tenax Therapeutics price target lowered to $4 from $26 at Leerink
PremiumThe Fly
Tenax Therapeutics price target lowered to $4 from $26 at Leerink
12d ago
TENX
Tenax Therapeutics downgraded to In Line from Outperform at Evercore ISI
PremiumThe Fly
Tenax Therapeutics downgraded to In Line from Outperform at Evercore ISI
13d ago
TENX
Tenax Therapeutics downgraded to Market Perform from Outperform at William Blair
PremiumThe FlyTenax Therapeutics downgraded to Market Perform from Outperform at William Blair
13d ago
TENX
Tenax Therapeutics price target lowered to $5 from $30 at Roth Capital
Premium
The Fly
Tenax Therapeutics price target lowered to $5 from $30 at Roth Capital
13d ago
TENX
Tenax sinks 87% to $1.69 after hypertension study failure
Premium
The Fly
Tenax sinks 87% to $1.69 after hypertension study failure
13d ago
TENX
Video: Apple slips as Jefferies downgrades to sell
PremiumThe Fly
Video: Apple slips as Jefferies downgrades to sell
13d ago
AAPL
META
Tenax Therapeutics Phase 3 LEVEL Trial Topline Results
PremiumCompany Announcements
Tenax Therapeutics Phase 3 LEVEL Trial Topline Results
13d ago
8K
TENX
Tenax Therapeutics reports LEVEL trial did not meet primary endpoint
PremiumThe Fly
Tenax Therapeutics reports LEVEL trial did not meet primary endpoint
13d ago
TENX
Tenax Therapeutics: Buy Rating Ahead of August LEVEL Phase III Catalyst, Attractive Risk/Reward in Underserved PH-HFpEF Market
PremiumRatings
Tenax Therapeutics: Buy Rating Ahead of August LEVEL Phase III Catalyst, Attractive Risk/Reward in Underserved PH-HFpEF Market
23d ago
TENX
Tenax Therapeutics reports Q2 EPS (35c), consensus (36c)
PremiumThe FlyTenax Therapeutics reports Q2 EPS (35c), consensus (36c)
23d ago
TENX
Tenax Therapeutics initiated with a Buy at Canaccord
Premium
The Fly
Tenax Therapeutics initiated with a Buy at Canaccord
26d ago
TENX
Tenax Therapeutics initiated with a Buy at Canaccord
Premium
The Fly
Tenax Therapeutics initiated with a Buy at Canaccord
26d ago
TENX
Tenax Therapeutics initiated with an Outperform at Evercore ISI
PremiumThe Fly
Tenax Therapeutics initiated with an Outperform at Evercore ISI
1M ago
TENX
Three Years of War Changed What Governments Buy. One Player is Already Winning Contracts (NASDAQ: MDWD)
PremiumTipRanks Newswire
Three Years of War Changed What Governments Buy. One Player is Already Winning Contracts (NASDAQ: MDWD)
2M ago
ESLT
KTOS
Tenax Therapeutics highlights key Phase 3 LEVEL trial
PremiumCompany Announcements
Tenax Therapeutics highlights key Phase 3 LEVEL trial
2M ago
8K
TENX
Tenax and Orion Secure Long-Term Levosimendan Supply Deal
PremiumCompany Announcements
Tenax and Orion Secure Long-Term Levosimendan Supply Deal
2M ago
8K
TENX
Tenax Therapeutics Updates Executive and Employee Severance Protections
PremiumCompany AnnouncementsTenax Therapeutics Updates Executive and Employee Severance Protections
2M ago
8K
TENX
Tenax Therapeutics price target raised to $40 from $34 at Guggenheim
Premium
The Fly
Tenax Therapeutics price target raised to $40 from $34 at Guggenheim
2M ago
TENX
Tenax Therapeutics initiated with a Buy at Chardan
Premium
The Fly
Tenax Therapeutics initiated with a Buy at Chardan
2M ago
TENX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >